Todd Pettingill

Corporate Officer/Principal presso OMNIAB, INC.

Health Technology

Consumer Services

Commercial Services

Profilo

Todd Pettingill is currently the Vice President of Business Development and Strategy at OmniAb Operations, Inc. and OmniAb, Inc. He previously worked as a Senior Manager of Corporate Development at Ligand Pharmaceuticals, Inc. Mr. Pettingill received his undergraduate degree from Brigham Young University and his MBA from UCLA Anderson School of Management.

Posizioni attive di Todd Pettingill

Società	Posizione	Inizio
OMNIAB, INC.	Corporate Officer/Principal	-
OmniAb Operations, Inc. OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.	Corporate Officer/Principal	-

Tutte le posizioni attive di Todd Pettingill

Precedenti posizioni note di Todd Pettingill

Società	Posizione	Fine
LIGAND PHARMACEUTICALS INCORPORATED	Investor Relations Contact	-

Vedi nel dettaglio l'esperienza di Todd Pettingill

Formazione di Todd Pettingill

Brigham Young University	Undergraduate Degree
UCLA Anderson School of Management	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Todd Pettingill

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
LIGAND PHARMACEUTICALS INCORPORATED	Health Technology
OMNIAB, INC.	Commercial Services

Aziende private	1
OmniAb Operations, Inc. OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.	Health Technology